Brief: Galapagos 9M Revenue EUR 211.4 Million
05/11/2025 21:01
Nov 05 (Reuters) - Galapagos 9M net income EUR -461.3 million. 9M cash & investments EUR 3,050.1 million
Recent news on Lakefront Biotherapeutics NV
See all newsBrief: Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline
Brief: Lakefront Receives Transparency Notification From Bank Of America
Belgium's Galapagos Q1 revenue falls 91% but returns to profit
Brief: Galapagos, Gilead Enter Binding Agreement On Ouro Medicines Acquisition
Brief: Galapagos Announces Nomination Of Gino Santini To Its Board Of Directors